<article title='Candidiasis'><paragraph><template><target>Hatnote</target><arg>Thrush (infection) redirects here. For other uses see [[thrush (disambiguation)]].</arg></template><template><target>Infobox disease</target><arg name="Name"><space/>Candidiasis 
</arg><arg name="Image"><space/>Human tongue infected with oral candidiasis.jpg
</arg><arg name="Caption"><space/>Oral candidiasis (thrush)
</arg><arg name="field"><space/>[[Infectious disease (medical specialty)|Infectious disease]]
</arg><arg name="DiseasesDB"><space/>1929
</arg><arg name="ICD10"><space/>{{ICD10|B|37||b|35}}
</arg><arg name="ICD9"><space/>{{ICD9|112}}
</arg><arg name="ICDO"><space/>
</arg><arg name="OMIM"><space/>
</arg><arg name="MedlinePlus"><space/>001511
</arg><arg name="eMedicineSubj"><space/>med
</arg><arg name="eMedicineTopic"><space/>264
</arg><arg name="eMedicine_mult"><space/>{{eMedicine2|emerg|76}} {{eMedicine2|ped|312}} {{eMedicine2|derm|67}}
</arg><arg name="MeshID"><space/>D002177
</arg></template></paragraph><paragraph><bold>Candidiasis</bold><space/>is a<space/><link><target>Fungal infection in animals</target><part>fungal infection</part></link><space/>due to any type of<space/><italics><link><target>Candida (genus)</target><part>Candida</part></link></italics><space/>(a type of<space/><link><target>yeast</target></link>).<extension extension_name='ref' name="CDC2014Can"><template><target>cite web</target><arg name="title">Candidiasis</arg><arg name="url">http://www.cdc.gov/fungal/diseases/candidiasis/</arg><arg name="website">cdc.gov</arg><arg name="accessdate">28 December 2014</arg><arg name="date">February 13, 2014</arg></template></extension><space/>When it affects the<space/><link><target>Oral candidiasis</target><part>mouth</part></link>, it is commonly called<space/><bold>thrush</bold>.<extension extension_name='ref' name="CDC2014Can"></extension><space/>Signs and symptoms include white patches on the tongue or other areas of the mouth and throat.<extension extension_name='ref' name="CDC2014OralS"><template><target>cite web</target><arg name="title">Symptoms of Oral Candidiasis
</arg><arg name="url">http://www.cdc.gov/fungal/diseases/candidiasis/thrush/symptoms.html</arg><arg name="website">cdc.gov</arg><arg name="accessdate">28 December 2014</arg><arg name="date">February 13, 2014</arg></template></extension><space/>Other symptoms may include soreness and problems swallowing.<extension extension_name='ref' name="CDC2014OralS"></extension><space/>When it affects the vagina, it is commonly called a<space/><bold>yeast infection</bold>.<extension extension_name='ref' name="CDC2014Can"></extension><space/>Signs and symptoms include genital itching, burning, and sometimes a white &quot;cottage cheese-like&quot; discharge from the vagina.<extension extension_name='ref'><template><target>cite web</target><arg name="title">Symptoms of Genital / Vulvovaginal Candidiasis</arg><arg name="url">http://www.cdc.gov/fungal/diseases/candidiasis/genital/symptoms.html</arg><arg name="website">cdc.gov</arg><arg name="accessdate">28 December 2014</arg><arg name="date">February 13, 2014</arg></template></extension><space/>Less commonly the penis may be affected, resulting in itchiness.<extension extension_name='ref' name="CDC2014OralS"></extension><space/>Very rarely, the infection may become invasive spreading throughout the body, resulting in<space/><link><target>fever</target><trail>s</trail></link><space/>along with other symptoms depending on the parts of the body affected.<extension extension_name='ref'><template><target>cite web</target><arg name="title">Symptoms of Invasive Candidiasis</arg><arg name="url">http://www.cdc.gov/fungal/diseases/candidiasis/invasive/symptoms.html</arg><arg name="website">cdc.gov</arg><arg name="accessdate">28 December 2014</arg><arg name="date">February 13, 2014</arg></template></extension></paragraph><preblock><preline>More than 20 types of<space/><italics>Candida</italics><space/>can cause infection with<space/><italics><link><target>Candida albicans</target></link></italics><space/>being the most common.<extension extension_name='ref' name="CDC2014Can"></extension><space/>Infections of the mouth are most common among children less than one month old, the elderly, and those with<space/><link><target>immunodeficiency</target><part>weak immune systems</part></link>. Conditions that result in a weak immune system include<space/><link><target>HIV/AIDS</target></link>, the medications used after<space/><link><target>organ transplantation</target></link>,<space/><link><target>diabetes</target></link>, and the use of<space/><link><target>corticosteroid</target><trail>s</trail></link>. Other risks include<space/><link><target>denture</target><trail>s</trail></link><space/>and following<space/><link><target>antibiotic</target></link><space/>therapy.<extension extension_name='ref' name="CDC2014RiskO"><template><target>cite web</target><arg name="title">Risk & Prevention</arg><arg name="url">http://www.cdc.gov/fungal/diseases/candidiasis/thrush/risk-prevention.html</arg><arg name="website">cdc.gov</arg><arg name="accessdate">28 December 2014</arg><arg name="date">February 13, 2014</arg></template></extension><space/>Vaginal infections occur more commonly during<space/><link><target>pregnancy</target></link>, in those with weak immune systems, and following antibiotic use.<extension extension_name='ref' name="CDC2014VP"><template><target>cite web</target><arg name="title">People at Risk for Genital / Vulvovaginal Candidiasis</arg><arg name="url">http://www.cdc.gov/fungal/diseases/candidiasis/genital/risk-prevention.html</arg><arg name="website">cdc.gov</arg><arg name="accessdate">28 December 2014</arg><arg name="date">February 13, 2014</arg></template></extension><space/>Risk for widespread infection includes being in an<space/><link><target>intensive care unit</target></link>, following surgery,<space/><link><target>low birth weight infant</target><trail>s</trail></link>, and those with weak immune systems.<extension extension_name='ref' name="CDC2014IP"><template><target>cite web</target><arg name="title">People at Risk for Invasive Candidiasis</arg><arg name="url">http://www.cdc.gov/fungal/diseases/candidiasis/invasive/risk-prevention.html</arg><arg name="website">cdc.gov</arg><arg name="accessdate">28 December 2014</arg><arg name="date">February 13, 2014</arg></template></extension></preline></preblock><preblock><preline>Efforts to prevent infections of the mouth include the use of<space/><link><target>chlorhexidine</target></link><space/>mouth wash in those with poor immune function and washing out the mouth following the use of inhaled steroids.<extension extension_name='ref' name="CDC2014Otx"></extension><space/>Little evidence supports<space/><link><target>probiotics</target></link><space/>for either prevention or treatment even among those with frequent vaginal infections.<extension extension_name='ref' name="Jur2012"><template><target>cite journal</target><arg name="author"><space/>Jurden L, Buchanan M, Kelsberg G, Safranek S<space/></arg><arg name="title"><space/>Clinical inquiries. Can probiotics safely prevent recurrent vaginitis?<space/></arg><arg name="journal"><space/>The Journal of family practice<space/></arg><arg name="volume"><space/>61<space/></arg><arg name="issue"><space/>6<space/></arg><arg name="pages"><space/>357, 368<space/></arg><arg name="date"><space/>June 2012<space/></arg><arg name="pmid"><space/>22670239<space/></arg></template></extension><extension extension_name='ref' name="Ab2009"><template><target>cite journal</target><arg name="author"><space/>Abad CL, Safdar N<space/></arg><arg name="title"><space/>The role of lactobacillus probiotics in the treatment or prevention of urogenital infections--a systematic review.<space/></arg><arg name="journal"><space/>Journal of chemotherapy (Florence, Italy)<space/></arg><arg name="volume"><space/>21<space/></arg><arg name="issue"><space/>3<space/></arg><arg name="pages"><space/>243–52<space/></arg><arg name="date"><space/>June 2009<space/></arg><arg name="pmid"><space/>19567343<space/></arg><arg name="doi"><space/>10.1179/joc.2009.21.3.243<space/></arg></template></extension><space/>For infections of the mouth, treatment with<space/><link><target>topical</target></link><space/><link><target>clotrimazole</target></link><space/>or<space/><link><target>nystatin</target></link><space/>is usually effective. Oral or intravenous<space/><link><target>fluconazole</target></link>,<space/><link><target>itraconazole</target></link>, or<space/><link><target>amphotericin B</target></link><space/>may be used if these do not work.<extension extension_name='ref' name="CDC2014Otx"><template><target>cite web</target><arg name="title">Treatment & Outcomes of Oral Candidiasis</arg><arg name="url">http://www.cdc.gov/fungal/diseases/candidiasis/thrush/treatment.html</arg><arg name="website">cdc.gov</arg><arg name="accessdate">28 December 2014</arg><arg name="date">February 13, 2014</arg></template></extension><space/>A number of topical antifungal medications may be used for vaginal infections including clotrimazole.<extension extension_name='ref'><template><target>cite web</target><arg name="title">Treatment & Outcomes of Genital / Vulvovaginal Candidiasis</arg><arg name="url">http://www.cdc.gov/fungal/diseases/candidiasis/genital/treatment.html</arg><arg name="website">cdc.gov</arg><arg name="accessdate">28 December 2014</arg><arg name="date">February 13, 2014</arg></template></extension><space/>In those with widespread disease, a number of weeks of intravenous amphotericin B is often used.<extension extension_name='ref'><template><target>cite web</target><arg name="title">Treatment & Outcomes of Invasive Candidiasis</arg><arg name="url">http://www.cdc.gov/fungal/diseases/candidiasis/invasive/treatment.html</arg><arg name="website">cdc.gov</arg><arg name="accessdate">28 December 2014</arg><arg name="date">February 13, 2014</arg></template></extension><space/>In certain groups at very high risk antifungal medications may be used preventatively.<extension extension_name='ref' name="CDC2014IP"></extension></preline></preblock><preblock><preline>Infections of the mouth occur in about 6% of babies less than a month old. About 20% of those receiving<space/><link><target>chemotherapy</target></link><space/>for cancer and 20% of those with<space/><link><target>AIDS</target></link><space/>also develop the disease.<extension extension_name='ref' name="Oral2014Stat"><template><target>cite web</target><arg name="title">Oral Candidiasis Statistics</arg><arg name="url">http://www.cdc.gov/fungal/diseases/candidiasis/thrush/statistics.html</arg><arg name="website">cdc.gov</arg><arg name="accessdate">28 December 2014</arg><arg name="date">February 13, 2014</arg></template></extension><space/>About three-quarters of women have at least one yeast infection at some time during their lives.<extension extension_name='ref'><template><target>cite web</target><arg name="title">Genital / vulvovaginal candidiasis (VVC)</arg><arg name="url">http://www.cdc.gov/fungal/diseases/candidiasis/genital/index.html</arg><arg name="website">cdc.gov</arg><arg name="accessdate">28 December 2014</arg><arg name="date">February 13, 2014</arg></template></extension><space/>Widespread disease is rare except in those who have risk factors.<extension extension_name='ref'><template><target>cite web</target><arg name="title">Invasive Candidiasis Statistics</arg><arg name="url">http://www.cdc.gov/fungal/diseases/candidiasis/invasive/statistics.html</arg><arg name="website">cdc.gov</arg><arg name="accessdate">28 December 2014</arg><arg name="date">February 13, 2014</arg></template></extension><space/>These diseases are also known technically as<space/><bold>candidosis</bold>,<space/><bold>moniliasis</bold>, and<space/><bold>oidiomycosis</bold>.<extension extension_name='ref' name="Andrews"><template><target>cite book</target><arg name="author">James, William D.; Berger, Timothy G.<space/></arg><arg name="title">Andrews' Diseases of the Skin: clinical Dermatology<space/></arg><arg name="publisher">Saunders Elsevier</arg><arg name="pages">308–311</arg><arg name="year">2006<space/></arg><arg name="isbn">0-7216-2921-0</arg><arg name="display-authors">etal</arg></template></extension></preline></preblock><heading level='2'>Signs and symptoms</heading><paragraph><link><target>File:Derm-57.jpg</target><part>thumb</part><part>Skin candidiasis</part></link><link><target>File:Toefungus.jpg</target><part>thumb</part><part>Nail candidiasis (<link><target>onychomycosis</target></link>)</part></link>Signs and symptoms of candidiasis vary depending on the area affected.<extension extension_name='ref' name="ID10"></extension><space/>Most candidal infections result in minimal complications such as redness, itching, and discomfort, though complications may be severe or even fatal if left untreated in certain populations. In<space/><link><target>immunocompetence</target><part>immunocompetent</part></link><space/>persons, candidiasis is usually a very localized infection of the skin or mucosal membranes, including the<space/><link><target>oral cavity</target></link><space/>(<link><target>oral thrush</target><part>thrush</part></link>), the<space/><link><target>pharynx</target></link><space/>or<space/><link><target>esophagus</target></link>, the<space/><link><target>gastrointestinal tract</target></link>, the<space/><link><target>rectum</target></link>,<space/><link><target>anus</target></link>, perianal/perirectal or ano-rectal area (in men as well as women),<extension extension_name='ref' name="PubMed PMID 2626187"><template><target>cite web</target><arg name="author1">Corno F.</arg><arg name="author2">Caldart M.</arg><arg name="author3">Toppino M.</arg><arg name="author4">Tapparo A.</arg><arg name="author5">Capozzi MP.</arg><arg name="author6">Goitre M.</arg><arg name="author7">Forte M.</arg><arg name="author8">Forcheri V.</arg><arg name="author9">Cervetti O</arg><arg name="title">[Ano-rectal candidiasis.] [La candidosi ano-rettale.]</arg><arg name="url">http://www.ncbi.nlm.nih.gov/pubmed/2626187</arg><arg name="website">PubMed/MEDLINE</arg><arg name="publisher">Minerva Chirurgica</arg><arg name="accessdate">30 January 2015</arg><arg name="archiveurl">http://www.ncbi.nlm.nih.gov/pubmed/2626187</arg><arg name="archivedate">Nov 15, 1989<space/></arg><arg name="location">National Library of Medicine</arg><arg name="pages">1</arg><arg name="language">English [Original Article in Italian]</arg><arg name="date">1989-11-15</arg></template></extension><space/>the<space/><link><target>perineum</target></link>, the<space/><link><target>urinary bladder</target></link>, the fingernails or toenails (onychomycosis), and the genitalia (<link><target>vagina</target></link>,<space/><link><target>penis</target></link>, etc.).<extension extension_name='ref' name="Baron"><template><target>cite book</target><arg name="author"><space/>Walsh TJ, Dixon DM<space/></arg><arg name="chapter">Deep Mycoses<space/></arg><arg name="title">Baron's Medical Microbiology<space/></arg><arg name="editor">Baron S eds.</arg><arg name="edition"><space/>4th<space/></arg><arg name="publisher"><space/>Univ of Texas Medical Branch<space/></arg><arg name="year"><space/>1996<space/></arg><arg name="isbn">0-9631172-1-1<space/></arg><arg name="url">http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid</arg><arg name="display-editors">etal</arg></template></extension></paragraph><paragraph>Candidiasis is a very common cause of vaginal irritation, or<space/><link><target>vaginitis</target></link>, and can also occur on the<space/><link><target>male genitals</target></link>. In immunocompromised patients,<space/><italics>Candida</italics><space/>infections can affect the<space/><link><target>esophageal candidiasis</target><part>esophagus</part></link><space/>with the potential of becoming<space/><link><target>systemic disease</target><part>systemic</part></link>, causing a much more serious condition, a<space/><link><target>fungemia</target></link><space/>called candidemia.<extension extension_name='ref' name="Fidel"><template><target>cite journal</target><arg name="author"><space/>Fidel PL<space/></arg><arg name="title"><space/>Immunity to Candida<space/></arg><arg name="journal"><space/>Oral Dis.<space/></arg><arg name="volume"><space/>8<space/></arg><arg name="pages"><space/>69–75<space/></arg><arg name="year"><space/>2002<space/></arg><arg name="pmid"><space/>12164664<space/></arg><arg name="doi"><space/>10.1034/j.1601-0825.2002.00015.x<space/></arg></template></extension><extension extension_name='ref' name="Pappas"><template><target>cite journal</target><arg name="author"><space/>Pappas PG<space/></arg><arg name="title"><space/>Invasive candidiasis<space/></arg><arg name="journal"><space/>Infect. Dis. Clin. North Am.<space/></arg><arg name="volume"><space/>20<space/></arg><arg name="issue"><space/>3<space/></arg><arg name="pages"><space/>485–506<space/></arg><arg name="year"><space/>2006<space/></arg><arg name="pmid"><space/>16984866<space/></arg><arg name="doi"><space/>10.1016/j.idc.2006.07.004<space/></arg></template></extension></paragraph><paragraph>Thrush is commonly seen in infants. It is not considered abnormal in infants unless it lasts longer than a few weeks.<extension extension_name='ref'><template><target>cite web</target><arg name="title"><space/>Thrush</arg><arg name="url">http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001650/<space/></arg><arg name="year">2011<space/></arg><arg name="accessdate">2011-04-08</arg></template></extension></paragraph><paragraph>Infection of the vagina or<space/><link><target>vulva</target></link><space/>may cause severe itching, burning, soreness, irritation, and a whitish or whitish-gray<space/><link><target>cottage cheese</target></link>-like discharge. These symptoms are also present in the more common<space/><link><target>bacterial vaginosis</target></link>.<extension extension_name='ref'><template><target>cite web</target><arg name="url">http://women.webmd.com/features/is-it-yeast-infection<space/></arg><arg name="author">Terri Warren, RN<space/></arg><arg name="title">Is It a Yeast Infection?<space/></arg><arg name="year">2010<space/></arg><arg name="accessdate">2011-02-23</arg></template></extension><space/>In a 2002 study, only 33% of women who were self-treating for a yeast infection actually had a such an infection, while most had either bacterial vaginosis or a mixed-type infection.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Ferris DG, Nyirjesy P, Sobel JD, Soper D, Pavletic A, Litaker MS<space/></arg><arg name="title"><space/>Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasis<space/></arg><arg name="journal"><space/>Obstetrics and Gynecology<space/></arg><arg name="volume"><space/>99<space/></arg><arg name="issue"><space/>3<space/></arg><arg name="pages"><space/>419–425<space/></arg><arg name="date"><space/>March 2002<space/></arg><arg name="pmid"><space/>11864668<space/></arg><arg name="doi"><space/>10.1016/S0029-7844(01)01759-8<space/></arg></template></extension><space/>Symptoms of infection of the male genitalia (balanitis thrush) include red skin around the head of the penis, swelling, irritation, itchiness and soreness of the head of the penis, thick, lumpy discharge under the foreskin, unpleasant odour, difficulty retracting the foreskin (<link><target>phimosis</target></link>), and pain when passing urine or during sex.<extension extension_name='ref'><link type='external' href='http://www.nhs.uk/Conditions/Thrush-men/Pages/Symptoms.aspx'>NHS: Symptoms of thrush in men (balanitis thrush)</link></extension></paragraph><paragraph>Perianal candidiasis can cause<space/><link><target>pruritis ani</target></link>. The lesion can be erythematous, papular, or ulcerative in appearance, and it is not considered to be a<space/><link><target>sexually transmissible disease</target></link>.<extension extension_name='ref'><template><target>cite book</target><arg name="editors">Bruce G. Wolff et al.</arg><arg name="title">The ASCRS textbook of colon and rectal surgery</arg><arg name="year">2007</arg><arg name="publisher">Springer</arg><arg name="location">New York</arg><arg name="isbn">0-387-24846-3</arg><arg name="pages">241, 242, 245</arg></template></extension></paragraph><paragraph>Esophageal candidiasis can cause<space/><link><target>dysphagia</target><part>difficulty swallowing</part></link>, or less commonly<space/><link><target>odynophagia</target><part>painful swallowing</part></link>.<extension extension_name='ref' name="Yamada 2009"></extension></paragraph><paragraph>Abnormal proliferation of the candida in the gut may lead to dysbiosis.<extension extension_name='ref' name="ReferenceA"><template><target>cite journal</target><arg name="last1">Mukherjee</arg><arg name="first1">PK</arg><arg name="last2">Sendid</arg><arg name="first2">B</arg><arg name="last3">Hoarau</arg><arg name="first3">G</arg><arg name="last4">Colombel</arg><arg name="first4">JF</arg><arg name="last5">Poulain</arg><arg name="first5">D</arg><arg name="last6">Ghannoum</arg><arg name="first6">MA</arg><arg name="title">Mycobiota in gastrointestinal diseases.</arg><arg name="journal">Nature reviews. Gastroenterology & hepatology</arg><arg name="date">February 2015</arg><arg name="volume">12</arg><arg name="issue">2</arg><arg name="pages">77–87</arg><arg name="pmid">25385227</arg></template></extension><space/>While it is not yet clear, this alteration may be the source of symptoms generally described as the<space/><link><target>irritable bowel syndrome</target></link>,<extension extension_name='ref'><template><target>cite journal</target><arg name="last1">Santelmann</arg><arg name="first1">H</arg><arg name="last2">Howard</arg><arg name="first2">JM</arg><arg name="title">Yeast metabolic products, yeast antigens and yeasts as possible triggers for irritable bowel syndrome.</arg><arg name="journal">European journal of gastroenterology & hepatology</arg><arg name="date">January 2005</arg><arg name="volume">17</arg><arg name="issue">1</arg><arg name="pages">21–6</arg><arg name="pmid">15647635</arg></template></extension><extension extension_name='ref'><template><target>cite journal</target><arg name="last1">Collins</arg><arg name="first1">SM</arg><arg name="title">A role for the gut microbiota in IBS.</arg><arg name="journal">Nature reviews. Gastroenterology & hepatology</arg><arg name="date">August 2014</arg><arg name="volume">11</arg><arg name="issue">8</arg><arg name="pages">497–505</arg><arg name="pmid">24751910</arg></template></extension><space/>and other gastrointestinal diseases.<extension extension_name='ref'><template><target>cite journal</target><arg name="last1">Wang</arg><arg name="first1">ZK</arg><arg name="last2">Yang</arg><arg name="first2">YS</arg><arg name="last3">Stefka</arg><arg name="first3">AT</arg><arg name="last4">Sun</arg><arg name="first4">G</arg><arg name="last5">Peng</arg><arg name="first5">LH</arg><arg name="title">Review article: fungal microbiota and digestive diseases.</arg><arg name="journal">Alimentary pharmacology & therapeutics</arg><arg name="date">April 2014</arg><arg name="volume">39</arg><arg name="issue">8</arg><arg name="pages">751–66</arg><arg name="pmid">24612332</arg></template></extension><extension extension_name='ref'><template><target>cite journal</target><arg name="last1">Gouba</arg><arg name="last2">Drancourt</arg><arg name="date">2015</arg><arg name="title">Digestive tract mycobiota: a source of infection.</arg><arg name="journal">Médecine et Maladies Infectieuses</arg><arg name="pmid">25684583</arg></template></extension></paragraph><heading level='2'>Causes</heading><paragraph><template><target>Main</target><arg>Candida (fungus)</arg></template><italics>Candida</italics><space/>yeasts are generally present in healthy humans, frequently part of the human body's normal oral and intestinal flora, and particularly on the skin; however, their growth is normally limited by the human<space/><link><target>immune system</target></link>, by competition of other<space/><link><target>microorganism</target><trail>s</trail></link>, such as bacteria occupying the same locations in the human body.<extension extension_name='ref' name="Goroll"><template><target>cite book</target><arg name="author">Mulley, A. G.; Goroll, A. H.</arg><arg name="title">Primary Care Medicine: office evaluation and management of the adult patient<space/></arg><arg name="publisher">Wolters Kluwer Health<space/></arg><arg name="location">Philadelphia<space/></arg><arg name="year">2006<space/></arg><arg name="pages">802–3<space/></arg><arg name="isbn">0-7817-7456-X<space/></arg><arg name="url">https://books.google.com/?id</arg><arg name="accessdate">2008-11-23</arg></template></extension><space/><italics>Candida</italics><space/>requires moisture for growth, notably on the skin.<extension extension_name='ref' name="Mims"><template><target>cite book</target><arg name="last">Goehring</arg><arg name="first">Richard V.</arg><arg name="title">Mims' medical microbiology.</arg><arg name="year">2008</arg><arg name="publisher">Mosby Elsevier</arg><arg name="location">Philadelphia, PA</arg><arg name="isbn">978-0-323-04475-2</arg><arg name="page">656</arg><arg name="edition">4th</arg></template></extension><space/>For example, wearing wet swimwear for long periods of time is believed to be a risk factor.<extension extension_name='ref' name="MedlinePlus"><template><target>MedlinePlusEncyclopedia</target><arg>001511</arg><arg>Vaginal yeast infection</arg></template></extension><space/>In extreme cases, superficial infections of the skin or mucous membranes may enter into the bloodstream and cause systemic<space/><italics>Candida</italics><space/>infections.</paragraph><paragraph>Diseases that increase the risk of candidiasis include<space/><link><target>HIV</target></link>/<link><target>AIDS</target></link>,<space/><link><target>EBV infectious mononucleosis</target><part>mononucleosis</part></link>,<space/><link><target>cancer</target></link><space/>treatments,<space/><link><target>steroids</target></link>,<space/><link><target>Stress (medicine)</target><part>stress</part></link>, antibiotics, diabetes, and nutrient deficiency.<space/><link><target>Hormone replacement therapy (menopause)</target><part>Hormone replacement therapy</part></link><space/>and infertility treatments may also be predisposing factors.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Nwokolo NC, Boag FC<space/></arg><arg name="title"><space/>Chronic vaginal candidiasis. Management in the postmenopausal patient<space/></arg><arg name="journal"><space/>Drugs Aging<space/></arg><arg name="volume"><space/>16<space/></arg><arg name="issue"><space/>5<space/></arg><arg name="pages"><space/>335–9<space/></arg><arg name="date"><space/>May 2000<space/></arg><arg name="pmid"><space/>10917071<space/></arg><arg name="doi"><space/>10.2165/00002512-200016050-00003<space/></arg></template></extension><space/>Treatment with antibiotics can lead to eliminating the yeast's natural competitors for resources in the oral and intestinal flora; thereby increasing the severity of the condition.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Bassetti M, Mikulska M, Viscoli C<space/></arg><arg name="title"><space/>Bench-to-bedside review: therapeutic management of invasive candidiasis in the intensive care unit.<space/></arg><arg name="journal"><space/>Critical Care<space/></arg><arg name="volume"><space/>14<space/></arg><arg name="issue"><space/>6<space/></arg><arg name="pages"><space/>244<space/></arg><arg name="date"><space/>December 2010<space/></arg><arg name="pmid"><space/>21144007<space/></arg><arg name="doi"><space/>10.1186/cc9239<space/></arg></template></extension><space/>A weakened or undeveloped immune system or metabolic illnesses are significant predisposing factors of candidiasis.<extension extension_name='ref' name="Odds"><template><target>cite journal</target><arg name="author"><space/>Odds FC<space/></arg><arg name="title"><space/>Candida infections: an overview<space/></arg><arg name="journal"><space/>Crit. Rev. Microbiol.<space/></arg><arg name="volume"><space/>15<space/></arg><arg name="issue"><space/>1<space/></arg><arg name="pages"><space/>1–5<space/></arg><arg name="year"><space/>1987<space/></arg><arg name="pmid"><space/>3319417<space/></arg><arg name="doi"><space/>10.3109/10408418709104444<space/></arg></template></extension><space/>Almost 15% of people with weakened immune systems develop a systemic illness caused by<space/><italics>Candida</italics><space/>species.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Choo ZW, Chakravarthi S, Wong SF, Nagaraja HS, Thanikachalam PM, Mak JW, Radhakrishnan A, Tay A<space/></arg><arg name="title"><space/>A comparative histopathological study of systemic candidiasis in association with experimentally induced breast cancer<space/></arg><arg name="journal"><space/>Oncology Letters<space/></arg><arg name="volume"><space/>1<space/></arg><arg name="issue"><space/>1<space/></arg><arg name="pages"><space/>215–222<space/></arg><arg name="year"><space/>2010<space/></arg><arg name="pmid"><space/>22966285<space/></arg><arg name="pmc"><space/>3436220<space/></arg><arg name="doi"><space/>10.3892/ol_00000039<space/></arg><arg name="url"><space/>http://www.spandidos-publications.com/ol/1/1/215<space/></arg><arg name="issn"><space/>1792-1082<space/></arg></template></extension><space/>Diets high in simple<space/><link><target>carbohydrates</target></link><space/>have been found to affect rates of oral candidiases.<extension extension_name='ref' name="Review2002"><template><target>cite journal</target><arg name="author"><space/>Akpan A, Morgan R<space/></arg><arg name="title"><space/>Oral candidiasis<space/></arg><arg name="journal"><space/>Postgraduate Medical Journal<space/></arg><arg name="volume"><space/>78<space/></arg><arg name="issue"><space/>922<space/></arg><arg name="pages"><space/>455–9<space/></arg><arg name="date"><space/>August 2002<space/></arg><arg name="pmid"><space/>12185216<space/></arg><arg name="pmc"><space/>1742467<space/></arg><arg name="doi"><space/>10.1136/pmj.78.922.455<space/></arg></template></extension></paragraph><paragraph><italics>C. albicans</italics><space/>was isolated from the vaginas of 19% of apparently healthy women, i.e., those who experienced few or no symptoms of infection. External use of detergents or<space/><link><target>douche</target><trail>s</trail></link><space/>or internal disturbances (hormonal or physiological) can<space/><link><target>Perturbation (biology)</target><part>perturb</part></link><space/>the normal<space/><link><target>vaginal flora</target></link>, consisting of<space/><link><target>lactic acid bacteria</target></link>, such as<space/><link><target>lactobacilli</target></link>, and result in an overgrowth of<space/><italics>Candida</italics><space/>cells, causing symptoms of infection, such as local<space/><link><target>inflammation</target></link>.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Mårdh PA, Novikova N, Stukalova E<space/></arg><arg name="title"><space/>Colonisation of extragenital sites by Candida in women with recurrent vulvovaginal candidosis<space/></arg><arg name="journal"><space/>BJOG<space/></arg><arg name="volume"><space/>110<space/></arg><arg name="issue"><space/>10<space/></arg><arg name="pages"><space/>934–7<space/></arg><arg name="date"><space/>October 2003<space/></arg><arg name="pmid"><space/>14550364<space/></arg><arg name="doi"><space/>10.1111/j.1471-0528.2003.01445.x<space/></arg><arg name="url"><space/>http://www.blackwell-synergy.com/openurl?genre</arg></template></extension><space/>Pregnancy and the use of oral contraceptives have been reported as risk factors.<extension extension_name='ref' name="Schiefer"><template><target>cite journal</target><arg name="author"><space/>Schiefer HG<space/></arg><arg name="title"><space/>Mycoses of the urogenital tract<space/></arg><arg name="journal"><space/>Mycoses<space/></arg><arg name="volume"><space/>40<space/></arg><arg name="issue"><space/>Suppl 2<space/></arg><arg name="pages"><space/>33–6<space/></arg><arg name="year"><space/>1997<space/></arg><arg name="pmid"><space/>9476502<space/></arg><arg name="doi"><space/>10.1111/j.1439-0507.1997.tb00561.x<space/></arg></template></extension><space/><link><target>Diabetes mellitus</target></link><space/>and the use of<space/><link><target>antibiotics</target></link><space/>are also linked to increased rates of yeast infections.<extension extension_name='ref' name="Schiefer"></extension></paragraph><paragraph>In penile candidiasis, the causes include sexual intercourse with an infected individual, low immunity, antibiotics, and diabetes. Male genital yeast infections are less common, and incidences of infection are only a fraction of those in women; however, yeast infection on the penis from direct contact via sexual intercourse with an infected partner is not uncommon.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>David LM, Walzman M, Rajamanoharan S<space/></arg><arg name="title"><space/>Genital colonisation and infection with candida in heterosexual and homosexual males<space/></arg><arg name="journal"><space/>Genitourin Med<space/></arg><arg name="volume"><space/>73<space/></arg><arg name="issue"><space/>5<space/></arg><arg name="pages"><space/>394–6<space/></arg><arg name="date"><space/>October 1997<space/></arg><arg name="pmid"><space/>9534752<space/></arg><arg name="pmc"><space/>1195901<space/></arg><arg name="doi"><space/>10.1136/sti.73.5.394<space/></arg></template></extension></paragraph><heading level='2'>Diagnosis</heading><paragraph><link><target>File:Candida albicans PHIL 3192 lores.jpg</target><part>thumb</part><part><link><target>Agar plate</target></link><space/>culture of ''C. albicans''</part></link><link><target>File:Vaginal wet mount of candidal vulvovaginitis.jpg</target><part>thumb</part><part><link><target>KOH test</target></link><space/>on a<space/><link><target>vaginal wet mount</target></link>, showing slings of pseudohyphae of ''<link><target>Candida albicans</target></link>'' surrounded by round vaginal epithelial cells, conferring a diagnosis of<space/><link><target>candidal vulvovaginitis</target></link></part></link><link><target>Image:Esophageal candidiasis (2) PAS stain.jpg</target><part>thumb</part><part>Micrograph of esophageal candidiasis showing hyphae,<space/><link><target>biopsy</target></link><space/>specimen,<space/><link><target>PAS stain</target></link></part></link></paragraph><paragraph>Diagnosis of a yeast infection is done either via microscopic examination or culturing. For identification by light microscopy, a scraping or swab of the affected area is placed on a<space/><link><target>microscope slide</target></link>. A single drop of 10%<space/><link><target>potassium hydroxide</target></link><space/>(KOH) solution is then added to the specimen. The KOH dissolves the skin cells, but leaves the<space/><italics>Candida</italics><space/>cells intact, permitting visualization of<space/><link><target>hyphae</target><part>pseudohyphae</part></link><space/>and budding<space/><link><target>yeast cell</target><trail>s</trail></link><space/>typical of many<space/><italics>Candida</italics><space/>species.</paragraph><paragraph>For the culturing method, a sterile swab is rubbed on the infected skin surface. The swab is then streaked on a culture medium. The culture is incubated at 37&amp;nbsp;C for several days, to allow development of yeast or bacterial colonies. The characteristics (such as morphology and colour) of the colonies may allow initial diagnosis of the organism causing disease symptoms.<extension extension_name='ref'><template><target>cite journal</target><arg name="author">Srikumar Chakravarthi, Nagaraja HS<space/></arg><arg name="title">A comprehensive review of the occurrence and management of systemic candidiasis as an opportunistic infection<space/></arg><arg name="journal">Microbiology Journal<space/></arg><arg name="volume">1<space/></arg><arg name="issue">2<space/></arg><arg name="pages">1–5<space/></arg><arg name="year">2010<space/></arg><arg name="url">http://scialert.net/abstract/?doi</arg><arg name="issn">2153-0696</arg></template></extension></paragraph><heading level='3'>Classification</heading><paragraph>Candidiasis may be divided into these types:<extension extension_name='ref' name="Andrews"></extension></paragraph><list type='bullet'><listitem>Mucosal candidiasis<list type='bullet'><listitem><link><target>Oral candidiasis</target></link><space/>(thrush, oropharyngeal candidiasis)<list type='bullet'><listitem>Pseudomembranous candidiasis</listitem><listitem>Erythematous candidiasis</listitem><listitem>Hyperplastic candidiasis</listitem><listitem><link><target>Denture-related stomatitis</target></link><space/><italics>Candida</italics><space/>organisms are involved in about 90% of cases</listitem><listitem><link><target>Angular stomatitis</target></link><space/><italics>Candida</italics><space/>species are responsible for about 20% of cases, mixed infection of<space/><italics>C. albicans</italics><space/>and<space/><italics><link><target>Staphylococcus aureus</target></link></italics><space/>for about 60% of cases.</listitem><listitem><link><target>Median rhomboid glossitis</target></link></listitem></list></listitem><listitem><link><target>Candidal vulvovaginitis</target></link><space/>(vaginal yeast infection)<extension extension_name='ref' name="Mastro2013"><template><target>cite journal</target><arg name="last1">Mastromarino</arg><arg name="first1">Paola</arg><arg name="last2">Vitali</arg><arg name="first2">Beatrice</arg><arg name="last3">Mosca</arg><arg name="first3">Luciana</arg><arg name="title">Bacterial vaginosis: a review on clinical trials with probiotics</arg><arg name="url">http://www.newmicrobiologica.org/PUB/allegati_pdf/2013/3/229.pdf</arg><arg name="journal">New Microbiologica</arg><arg name="date">2013</arg><arg name="volume">36</arg><arg name="pages">229–238</arg><arg name="pmid">23912864</arg></template></extension></listitem><listitem>Candidal<space/><link><target>balanitis</target></link>, infection of the glans penis, almost exclusively occurring in uncircumcised males<extension extension_name='ref' name="Nyirjesy 2013"><template><target>cite journal</target><arg name="author"><space/>Nyirjesy P, Sobel JD<space/></arg><arg name="title"><space/>Genital mycotic infections in patients with diabetes.<space/></arg><arg name="journal"><space/>Postgraduate Medicine<space/></arg><arg name="volume"><space/>125<space/></arg><arg name="issue"><space/>3<space/></arg><arg name="pages"><space/>33–46<space/></arg><arg name="date"><space/>May 2013<space/></arg><arg name="pmid"><space/>23748505<space/></arg><arg name="doi"><space/>10.3810/pgm.2013.05.2650<space/></arg></template></extension><space/></listitem><listitem><link><target>Esophageal candidiasis</target></link><space/>(candidal esophagitis)<extension extension_name='ref' name="Yamada 2009"><template><target>cite book</target><arg name="last">Yamada T, Alpers DH</arg><arg name="title">Textbook of gastroenterology</arg><arg name="year">2009</arg><arg name="publisher">Blackwell Pub.</arg><arg name="location">Chichester, West Sussex</arg><arg name="isbn">978-1-4051-6911-0</arg><arg name="edition">5th</arg><arg name="page">814</arg><arg name="display-authors">etal</arg></template></extension></listitem></list></listitem><listitem>Cutaneous candidiasis<list type='bullet'><listitem><link><target>Candidal intertrigo</target></link></listitem><listitem><link><target>Candidal paronychia</target></link></listitem><listitem><link><target>Perianal candidiasis</target></link></listitem><listitem><link><target>Candidid</target></link></listitem><listitem><link><target>Chronic mucocutaneous candidiasis</target></link></listitem><listitem><link><target>Congenital cutaneous candidiasis</target></link></listitem><listitem><link><target>Diaper candidiasis</target></link></listitem><listitem><link><target>Erosio interdigitalis blastomycetica</target></link></listitem></list></listitem><listitem><link><target>Onychomycosis</target></link><space/>(nail infection) caused by<space/><italics>Candida</italics><extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Nolting S, Brautigam M, Weidinger G<space/></arg><arg name="title"><space/>Terbinafine in onychomycosis with involvement by non-dermatophytic fungi<space/></arg><arg name="journal"><space/>The British journal of dermatology<space/></arg><arg name="volume"><space/>130 Suppl 43<space/></arg><arg name="pages"><space/>16–21<space/></arg><arg name="year"><space/>1994<space/></arg><arg name="pmid"><space/>8186136<space/></arg><arg name="doi"><space/>10.1111/j.1365-2133.1994.tb06088.x<space/></arg></template></extension></listitem><listitem>Invasive candidiasis<list type='bullet'><listitem><link><target>Systemic candidiasis</target></link><space/>(one organ system involved)</listitem><listitem>Disseminated candidiasis (multiple system involvement, e.g. &quot;hepatosplenic candidiasis&quot;, which sometimes follows<space/><link><target>neutropenia</target></link>; or &quot;candidemia&quot;, a form of<space/><link><target>septicemia</target></link>).<extension extension_name='ref' name="Reiss 2011"><template><target>cite book</target><arg name="last">Errol Reiss, H. Jean Shadomy, G. Marshall Lyon</arg><arg name="title">Fundamental medical mycology</arg><arg name="year">2011</arg><arg name="publisher">John Wiley & Sons</arg><arg name="location">Hoboken, N.J.</arg><arg name="isbn">978-1-118-10176-6</arg><arg name="url">https://books.google.com/books?id</arg><arg name="chapter">Chapter 11</arg></template></extension><space/>Ultrasound of liver shows wheel inside wheel sign (a central hypoechoic area (necrosis containing fungi) surrounded by an echogenic zone (inflammatory cells).</listitem></list></listitem><listitem><link><target>Antibiotic candidiasis</target></link><space/>(iatrogenic candidiasis)</listitem><listitem>Dysbiosis of the gut mycobiota<space/><extension extension_name='ref' name="ReferenceA"></extension></listitem></list><heading level='2'>Prevention</heading><paragraph>A diet that supports the immune system and is not high in simple carbohydrates contributes to a healthy balance of the oral and intestinal flora.<extension extension_name='ref' name="Goroll"></extension><extension extension_name='ref' name="Review2002"></extension><space/>While yeast infections are associated with diabetes, the level of blood sugar control may not affect the risk.<extension extension_name='ref'><template><target>cite book</target><arg name="last1">Mobley</arg><arg name="first1">David P. Cappelli, Connie C.</arg><arg name="title">Prevention in clinical oral health care</arg><arg name="date">2008</arg><arg name="publisher">Mosby Elsevier</arg><arg name="location">St. Louis, Mo.</arg><arg name="isbn">9780323036955</arg><arg name="page">254</arg><arg name="url">https://books.google.it/books?id</arg></template></extension><space/>Wearing cotton underwear may help to reduce the risk of developing skin and vaginal yeast infections, along with not wearing wet clothes for long periods of time.<extension extension_name='ref' name="CDC2014VP"></extension><extension extension_name='ref' name="MedlinePlus"></extension></paragraph><paragraph>Oral hygiene can help prevent oral candidiasis when people have a weakened immune system.<extension extension_name='ref' name="CDC2014RiskO"></extension><space/>For people undergoing cancer treatment, chlorhexidine mouthwash can prevent or reduce thrush.<extension extension_name='ref' name="CDC2014RiskO"></extension><space/>People who use inhaled corticosteroids can reduce the risk of developing oral candidiasis by rinsing the mouth with water or mouthwash after using the inhaler.<extension extension_name='ref' name="CDC2014RiskO"></extension></paragraph><paragraph>For women who experience recurrent yeast infections, there is limited evidence that oral or intravaginal probiotics help to prevent future infections.<extension extension_name='ref' name="Jur2012"></extension><extension extension_name='ref' name="Fal2006"><template><target>cite journal</target><arg name="last1">Falagas</arg><arg name="first1">ME</arg><arg name="last2">Betsi</arg><arg name="first2">GI</arg><arg name="last3">Athanasiou</arg><arg name="first3">S</arg><arg name="title">Probiotics for prevention of recurrent vulvovaginal candidiasis: a review.</arg><arg name="journal">The Journal of antimicrobial chemotherapy</arg><arg name="date">August 2006</arg><arg name="volume">58</arg><arg name="issue">2</arg><arg name="pages">266–72</arg><arg name="pmid">16790461</arg><arg name="quote">Thus, the available evidence for the use of probiotics for prevention of recurrent VVC is limited</arg></template></extension><space/>This includes either as pills or as yogurt.<extension extension_name='ref' name="Jur2012"></extension></paragraph><heading level='2'>Treatment</heading><paragraph>Candidiasis is commonly treated with<space/><link><target>antimycotic</target><trail>s</trail></link>; these<space/><link><target>antifungal drug</target><trail>s</trail></link><space/>include topical<space/><link><target>clotrimazole</target></link>, topical<space/><link><target>nystatin</target></link>,<space/><link><target>fluconazole</target></link>, and topical<space/><link><target>ketoconazole</target></link>.</paragraph><heading level='3'>Localized infection</heading><paragraph>Mouth and throat candidiasis are treated with antifungal medication. Oral candidiasis usually responds to topical treatments; otherwise, systemic antifungal medication may be needed for oral infections. Candida esophagitis may be treated orally or intravenously; for severe or azole-resistant esophageal candidiasis, treatment with amphotericin B may be necessary.<extension extension_name='ref' name="CDC2014Otx"></extension></paragraph><paragraph>A one-time dose of fluconazole is 90% effective in treating a vaginal yeast infection.<extension extension_name='ref' name="Moosa"><template><target>cite journal</target><arg name="author"><space/>Moosa MY, Sobel JD, Elhalis H, Du W, Akins RA<space/></arg><arg name="title"><space/>Fungicidal Activity of Fluconazole against Candida albicans in a Synthetic Vagina-Simulative Medium<space/></arg><arg name="journal"><space/>Antimicrob. Agents Chemother.<space/></arg><arg name="volume"><space/>48<space/></arg><arg name="issue"><space/>1<space/></arg><arg name="pages"><space/>161–7<space/></arg><arg name="year"><space/>2004<space/></arg><arg name="pmid"><space/>14693534<space/></arg><arg name="pmc"><space/>310176<space/></arg><arg name="doi"><space/>10.1128/AAC.48.1.161-167.2004<space/></arg></template></extension><space/>Local treatment may include vaginal<space/><link><target>suppository</target><part>suppositories</part></link><space/>or medicated<space/><link><target>douche</target><trail>s</trail></link>. Other types of yeast infections require different dosing.<space/><link><target>Gentian violet</target></link><space/>can be used for thrush in<space/><link><target>breastfeeding</target></link><space/>babies.<space/><italics>C. albicans</italics><space/>can develop resistance to fluconazole, this being more of an issue in those with HIV/AIDS who are often treated with multiple courses of fluconazole for recurrent oral infections.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Morschhäuser J<space/></arg><arg name="title"><space/>The genetic basis of fluconazole resistance development in Candida albicans.<space/></arg><arg name="journal"><space/>Biochimica et Biophysica Acta<space/></arg><arg name="volume"><space/>1587<space/></arg><arg name="issue"><space/>2-3<space/></arg><arg name="pages"><space/>240–8<space/></arg><arg name="date"><space/>Jul 18, 2002<space/></arg><arg name="pmid"><space/>12084466<space/></arg><arg name="doi"><space/>10.1016/s0925-4439(02)00087-x<space/></arg></template></extension></paragraph><paragraph>For vaginal yeast infection in<space/><link><target>pregnancy</target></link>, topical<space/><link><target>imidazole</target></link><space/>or<space/><link><target>triazole</target></link><space/>antifungals are considered the therapy of choice owing to available safety data.<extension extension_name='ref' name="soong2009"></extension><space/>Systemic absorption of these topical formulations is minimal, posing little risk of<space/><link><target>transplacental</target></link><space/>transfer.<extension extension_name='ref' name="soong2009"></extension><space/>In vaginal yeast infection in pregnancy, treatment with topical azole antifungals is recommended for 7 days instead of a shorter duration.<extension extension_name='ref' name="soong2009"><template><target>cite journal</target><arg name="author"><space/>Soong D, Einarson A<space/></arg><arg name="title"><space/>Vaginal yeast infections during pregnancy.<space/></arg><arg name="journal"><space/>Canadian family physician Medecin de famille canadien<space/></arg><arg name="volume"><space/>55<space/></arg><arg name="issue"><space/>3<space/></arg><arg name="pages"><space/>255–6<space/></arg><arg name="date"><space/>Mar 2009<space/></arg><arg name="pmid"><space/>19282531<space/></arg><arg name="pmc">2654841</arg></template></extension></paragraph><paragraph>No benefit from probiotics has been found for active infections.<extension extension_name='ref' name="Ab2009"></extension></paragraph><heading level='3'>Blood infection</heading><paragraph>Systemic candidiasis occurs when Candida yeast enters the bloodstream and may spread (becoming disseminated candidiasis) to other organs, including the<space/><link><target>central nervous system</target></link>, kidneys, liver, bones, muscles, joints, spleen, or eyes. Treatment typically consists of oral or<space/><link><target>intravenous</target></link><space/>antifungal medications.<extension extension_name='ref' name="NIHSystemic"><template><target>cite web</target><arg name="title">Systemic candidiasis</arg><arg name="url">http://rarediseases.info.nih.gov/gard/1076/systemic-candidiasis/resources/1<space/></arg><arg name="website">NIH.gov<space/></arg><arg name="publisher">U.S. DHHS, National Institute of Health<space/></arg><arg name="date"><space/>Oct 2014<space/></arg><arg name="accessdate">April 19, 2015</arg></template></extension><space/>In candidal infections of the blood, intravenous fluconazole or an<space/><link><target>echinocandin</target></link><space/>such as<space/><link><target>caspofungin</target></link><space/>may be used.<extension extension_name='ref' name="IDSA2009"><template><target>cite journal</target><arg name="author"><space/>Pappas PG, Kauffman CA, Andes D, Benjamin DK, Calandra TF, Edwards JE, Filler SG, Fisher JF, Kullberg BJ, Ostrosky-Zeichner L, Reboli AC, Rex JH, Walsh TJ, Sobel JD<space/></arg><arg name="title"><space/>Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.<space/></arg><arg name="journal"><space/>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America<space/></arg><arg name="volume"><space/>48<space/></arg><arg name="issue"><space/>5<space/></arg><arg name="pages"><space/>503–35<space/></arg><arg name="date"><space/>Mar 1, 2009<space/></arg><arg name="pmid"><space/>19191635<space/></arg><arg name="doi">10.1086/596757</arg></template></extension><space/><link><target>Amphotericin B</target></link><space/>is another option.<extension extension_name='ref' name="IDSA2009"></extension></paragraph><heading level='2'>Prognosis</heading><paragraph>Among individuals being treated in<space/><link><target>intensive care unit</target><trail>s</trail></link>, the<space/><link><target>mortality rate</target></link><space/>is about 30-50% when systemic candidiasis develops.<extension extension_name='ref' name="Williams 2011"><template><target>cite journal</target><arg name="author"><space/>Williams D, Lewis M<space/></arg><arg name="title"><space/>Pathogenesis and treatment of oral candidosis.<space/></arg><arg name="journal"><space/>Journal of oral microbiology<space/></arg><arg name="volume"><space/>3<space/></arg><arg name="date"><space/>Jan 28, 2011<space/></arg><arg name="pmid"><space/>21547018<space/></arg><arg name="pmc"><space/>3087208<space/></arg><arg name="doi">10.3402/jom.v3i0.5771</arg></template></extension></paragraph><heading level='2'>Epidemiology</heading><paragraph>Oral candidiasis is the most common fungal infection of the mouth,<extension extension_name='ref' name="OMF path textbook"><template><target>cite book</target><arg name="last">Bouquot</arg><arg name="first">Brad W. Neville , Douglas D. Damm, Carl M. Allen, Jerry E.</arg><arg name="title">Oral & maxillofacial pathology</arg><arg name="year">2002</arg><arg name="publisher">W.B. Saunders</arg><arg name="location">Philadelphia</arg><arg name="isbn">0-7216-9003-3</arg><arg name="pages">189–197</arg><arg name="edition">2.</arg></template></extension><space/>and it also represents the most common opportunistic oral infection in humans.<extension extension_name='ref' name="Lalla 2013"><template><target>cite journal</target><arg name="author"><space/>Lalla RV, Patton LL, Dongari-Bagtzoglou A<space/></arg><arg name="title"><space/>Oral candidiasis: pathogenesis, clinical presentation, diagnosis and treatment strategies.<space/></arg><arg name="journal"><space/>Journal of the California Dental Association<space/></arg><arg name="volume"><space/>41<space/></arg><arg name="issue"><space/>4<space/></arg><arg name="pages"><space/>263–8<space/></arg><arg name="date"><space/>April 2013<space/></arg><arg name="pmid"><space/>23705242<space/></arg></template></extension><space/>In the Western Hemisphere, about 75% of females are affected at some time in their lives with a vaginal yeast infection.</paragraph><paragraph>Esophageal candidiasis is the most common esophageal infection in persons with AIDS, and accounts for about 50% of all esophageal infections, often coexisting with other esophageal diseases. About two-thirds of people with AIDS and esophageal candidiasis also have oral candidiasis.<extension extension_name='ref' name="Yamada 2009"></extension></paragraph><paragraph>Candidal<space/><link><target>sepsis</target></link><space/>is rare.<extension extension_name='ref' name="Gow 2002"><template><target>cite journal</target><arg name="last">Gow</arg><arg name="first">Neil</arg><arg name="title">Candida albicans - a fungal Dr Jekyll and Mr Hyde</arg><arg name="journal">Mycologist</arg><arg name="date">8 May 2002</arg><arg name="volume">16</arg><arg name="issue">01</arg><arg name="doi">10.1017/S0269915X02006183</arg></template></extension><space/>Candida is the fourth most common cause of bloodstream infections among hospital patients in the United States.<extension extension_name='ref' name="CDCCandida"><template><target>cite web</target><arg name="title">Candida</arg><arg name="url">http://www.cdc.gov/hai/eip/pdf/Candida-factsheet.pdf</arg><arg name="website">CDC.gov</arg><arg name="publisher">Center of Disease Contrl</arg><arg name="accessdate">April 19, 2015</arg></template></extension></paragraph><heading level='2'>History</heading><paragraph>Descriptions of what sounds like oral thrush go back to the time of<space/><link><target>Hippocrates</target></link><space/><italics>circa</italics><space/>460 - 370 BCE.<extension extension_name='ref' name="ID10"><template><target>cite book</target><arg name="last">Dolin</arg><arg name="first">[edited by] Gerald L. Mandell, John E. Bennett, Raphael</arg><arg name="title">Mandell, Douglas, and Bennett's principles and practice of infectious diseases</arg><arg name="year">2010</arg><arg name="publisher">Churchill Livingstone/Elsevier</arg><arg name="location">Philadelphia, PA</arg><arg name="isbn">978-0-443-06839-3</arg><arg name="pages">Chapter 250</arg><arg name="edition">7th</arg></template></extension></paragraph><paragraph>Vulvovaginal candidiasis was first described in 1849 by Wilkinson.<extension extension_name='ref' name="Lynch 1994"></extension><space/>In 1875, Haussmann demonstrated the causative organism in both vulvovaginal and oral candidiasis is the same.<extension extension_name='ref' name="Lynch 1994"></extension></paragraph><paragraph>With the advent of antibiotics following World War II, the rates of candidiasis increased. The rates than decreased in the 1950s following the development of<space/><link><target>nystatin</target></link>.<extension extension_name='ref' name="Obladen 2012"><template><target>cite journal</target><arg name="author"><space/>Obladen M<space/></arg><arg name="title"><space/>Thrush - nightmare of the foundling hospitals.<space/></arg><arg name="journal"><space/>Neonatology<space/></arg><arg name="volume"><space/>101<space/></arg><arg name="issue"><space/>3<space/></arg><arg name="pages"><space/>159–65<space/></arg><arg name="year"><space/>2012<space/></arg><arg name="pmid"><space/>22024688<space/></arg><arg name="doi"><space/>10.1159/000329879<space/></arg></template></extension></paragraph><paragraph>The colloquial term &quot;thrush&quot; refers to the resemblance of the white flecks present in some forms of candidiasis (<italics>e.g.</italics><space/>pseudomembranous candidiasis) with the breast of the<space/><link><target>thrush (bird)</target><part>bird of the same name</part></link>.&lt;ref name=emedicine/medscape&gt;<template><target>cite web</target><arg name="last">Scully</arg><arg name="first">Crispian</arg><arg name="title">Mucosal Candidiasis (Medscape)</arg><arg name="url">http://emedicine.medscape.com/article/1075227-overview</arg><arg name="publisher">WebMD LLC</arg><arg name="accessdate">8 September 2013</arg></template>&lt;/ref&gt; The term candidosis is largely used in British English, and candidiasis in American English.<extension extension_name='ref' name="Lynch 1994"><template><target>cite journal</target><arg name="author"><space/>Lynch DP<space/></arg><arg name="title"><space/>Oral candidiasis. History, classification, and clinical presentation.<space/></arg><arg name="journal"><space/>Oral surgery, oral medicine, and oral pathology<space/></arg><arg name="volume"><space/>78<space/></arg><arg name="issue"><space/>2<space/></arg><arg name="pages"><space/>189–93<space/></arg><arg name="date"><space/>August 1994<space/></arg><arg name="pmid"><space/>7936588<space/></arg><arg name="doi"><space/>10.1016/0030-4220(94)90146-5<space/></arg></template></extension><space/><italics>Candida</italics><space/>is also pronounced differently, in American English, the stress is on the &quot;i&quot;, whereas in British English the stress is on the first syllable.</paragraph><paragraph>The<space/><link><target>genus</target></link><space/><italics>Candida</italics><space/>and<space/><link><target>species</target></link><space/><italics>C. albicans</italics><space/>were described by botanist<space/><link><target>Christine Marie Berkhout</target></link><space/>in her doctoral thesis at the<space/><link><target>University of Utrecht</target></link><space/>in 1923. Over the years, the classification of the genera and species has evolved. Obsolete names for this genus include<space/><italics>Mycotorula</italics><space/>and<space/><italics>Torulopsis</italics>. The species has also been known in the past as<space/><italics>Monilia albicans</italics><space/>and<space/><italics>Oidium albicans</italics>. The current classification is<space/><italics><link><target>nomen conservandum</target></link></italics>, which means the name is authorized for use by the International Botanical Congress (IBC).<extension extension_name='ref'><template><target>cite book</target><arg name="url">http://www.bgbm.org/iapt/nomenclature/code/SaintLouis/0000St.Luistitle.htm<space/></arg><arg name="title">International Code of Botanical Nomenclature<space/></arg><arg name="year">2000<space/></arg><arg name="isbn">3-904144-22-7<space/></arg><arg name="location">Königstein<space/></arg><arg name="accessdate">2008-11-23</arg></template></extension></paragraph><paragraph>The genus<space/><italics>Candida</italics><space/>includes about 150 different species; however, only a few are known to cause human infections.<space/><italics>C. albicans</italics><space/>is the most significant<space/><link><target>pathogen</target><trail>ic</trail></link><space/>species. Other species pathogenic in humans include<space/><italics>C. tropicalis</italics>,<space/><italics>C. glabrata</italics>,<space/><italics>C. krusei</italics>,<space/><italics>C. parapsilosis</italics>,<space/><italics>C. dubliniensis</italics>, and<space/><italics>C. lusitaniae</italics>.</paragraph><paragraph>The name<space/><italics>Candida</italics><space/>was proposed by Berkhout. It is from the Latin word<space/><italics>toga candida</italics>, referring to the white<space/><link><target>toga</target></link><space/>(robe) worn by candidates for the Senate of the ancient Roman republic.<extension extension_name='ref' name="Lynch 1994"></extension><space/>The specific epithet<space/><italics>albicans</italics><space/>also comes from Latin,<space/><italics>albicare</italics><space/>meaning &quot;to whiten&quot;.<extension extension_name='ref' name="Lynch 1994"></extension><space/>These names refer to the generally white appearance of<space/><italics>Candida</italics><space/>species when cultured.</paragraph><heading level='2'>Alternative medicine</heading><paragraph><template><target>See also</target><arg>List of questionable diseases</arg></template>What has been described as &quot;a large<space/><link><target>pseudoscience</target><part>pseudoscientific</part></link><space/>cult&quot;<extension extension_name='ref'><template><target>cite journal</target><arg name="last1">Odds</arg><arg name="first1">FC</arg><arg name="title">Candida infections: an overview.</arg><arg name="journal">Critical reviews in microbiology</arg><arg name="date">1987</arg><arg name="volume">15</arg><arg name="issue">1</arg><arg name="pages">1–5</arg><arg name="pmid">3319417</arg><arg name="doi">10.3109/10408418709104444</arg></template></extension><space/>has developed around the topic of<space/><italics>Candida</italics>, with claims up to one in three people are affected by conditions with terms such as systemic candidiasis, &quot;candidiasis hypersensitivity&quot;, fungal type<space/><link><target>dysbiosis</target></link>,<space/><italics>Candida</italics>-related complex, the yeast syndrome, yeast allergy, yeast overgrowth, or simply &quot;<italics>Candida</italics>&quot; or &quot;yeast problem&quot;.<extension extension_name='ref' name="Barrett2005"><template><target>cite web</target><arg name="author1">Stephen Barrett, M.D.</arg><arg name="title">Dubious "Yeast Allergies"</arg><arg name="url">http://www.quackwatch.org/01QuackeryRelatedTopics/candida.html</arg><arg name="date">October 8, 2005</arg></template></extension>Some practitioners of alternative medicine have promoted these purported conditions and sold dietary supplements as supposed cures; a number of them have been prosecuted.<extension extension_name='ref'><template><target>cite web</target><arg name="author">Barrett S<space/></arg><arg name="title">Dubious "Yeast Allergies"<space/></arg><arg name="url">http://www.quackwatch.org/01QuackeryRelatedTopics/candida.html<space/></arg><arg name="date">2005-10-08<space/></arg><arg name="publisher">QuackWatch<space/></arg><arg name="accessdate">2008-02-21</arg></template></extension><extension extension_name='ref' name="NCAHF"><template><target>cite web</target><arg name="url">http://www.ncahf.org/articles/c-d/candida.html<space/></arg><arg name="title">Candidiasis Hypersensitivity<space/></arg><arg name="accessdate">January 2014<space/></arg><arg name="publisher">[[National Council Against Health Fraud]]<space/></arg><arg name="author">Jarvis WT</arg></template></extension></paragraph><paragraph>In 1990, alternative health vendor Nature's Way signed an FTC consent agreement not to misrepresent in advertising any self-diagnostic test concerning yeast conditions or to make any unsubstantiated representation concerning any food or supplement's ability to control yeast conditions, with a fine of $30,000 payable to the<space/><link><target>National Institutes of Health</target></link><space/>for research in genuine candidiasis.<extension extension_name='ref' name="NCAHF"></extension></paragraph><heading level='2'>References</heading><paragraph><template><target>Reflist</target><arg>2</arg></template></paragraph><heading level='2'>External links</heading><paragraph><template><target>Commons category</target></template></paragraph><list type='bullet'><listitem><template><target>DMOZ</target><arg>Health/Conditions_and_Diseases/Infectious_Diseases/Fungal/Candida/</arg></template></listitem></list><paragraph><template><target>Diseases of the skin and appendages by morphology</target></template><template><target>Mycoses</target></template></paragraph><paragraph><template><target>Authority control</target></template></paragraph><paragraph><link><target>Category:Mycosis-related cutaneous conditions</target></link><link><target>Category:Fungal diseases</target></link><link><target>Category:RTT</target></link></paragraph></article>